CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | Stock-Other | 36.46% | — | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 24.98% | — | — | |
| 3 | ✓ | Corium Intl INC | Stock-Other | 15.99% | — | — | |
| 4 | ✓ | Entellus Medical INC | Stock-Other | 12.56% | — | — | |
| 5 | ✓ | Endologix INC | Stock-Other | 3.88% | — | — | |
| 6 | AXGN | Axogen INC | Stock-Other | 3.66% | — | — | |
| 7 | ✓ | Catalyst Biosciences INC | Stock-Other | 1.03% | — | — | |
| 8 | ACUR | Acura Pharmaceuticals INC | Stock-Other | 0.84% | — | — | |
| 9 | MNOV | Medicinova INC | Stock-Other | 0.60% | +0.14% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABMDEUR | Abiomed INC | +11% | — | Unchanged |
| 2 | MNOV | Medicinova INC | -0.2% | — | Unchanged |
| 3 | ✓ | Endologix INC | -0.6% | — | Unchanged |
| 4 | RVNCEUR | Revance Therapeutics INC | -1.5% | — | Unchanged |
| 5 | ✓ | Entellus Medical INC | -5.2% | — | Unchanged |
| 6 | ✓ | Corium Intl INC | -7.1% | — | Unchanged |
| 7 | AXGN | Axogen INC | — | NEW | New buy |
| 8 | ✓ | Acura Pharmaceuticals INC | — | EXIT | Sold out |
| 9 | ✓ | Catalyst Biosciences INC | — | NEW | New buy |
| 10 | ACUR | Acura Pharmaceuticals INC | — | NEW | New buy |